Digital Pathology Market

Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsulation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) & Region - Global Forecast to 2028

Report Code: HIT 2608 Jun, 2023, by marketsandmarkets.com

The global digital pathology market in terms of revenue was estimated to be worth $0.9 billion in 2023 and is poised to reach $1.8 billion by 2028, growing at a CAGR of 13.6% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth in the digital pathology industry is mainly driven by factors such as the growing awareness of early cancer diagnosis in emerging economies, growing applications of digital pathology in drug development and companion diagnostics, and the increasing adoption of digital pathology to enhance lab efficiency.

However, the high cost of digital pathology systems are expected to restrain market growth to a certain extent.

Global Digital Pathology Market Trends

Digital Pathology Market

To know about the assumptions considered for the study, Request for Free Sample Report

Digital Pathology Market

Digital Pathology Market Dynamics

Driver: Increasing adoption of digital pathology to enhance lab efficiency

Digital pathology helps improve lab efficiency by reducing costs, decreasing turnaround times, and providing users with access to subject-matter expertise. Improvements in lab efficiency are critical as patients and physicians depend on lab results for diagnostic decisions, and diagnostic tests must be completed and reported quickly & accurately. Moreover, access to digital slides via web services reduces shipping costs and travel time for pathologists. Currently, the demand for digital pathology solutions has increased as pathologists can remotely view diagnostic results for primary diagnosis.

Restraint: High cost of digital pathology systems

A typical digital pathology system, which includes a slide scanner, an image server, and software, costs around USD 500,000 to USD 10,00,000. A full-featured scanner itself costs around USD 2,50,000. The average price of a digital pathology scanner in the Asia Pacific is around USD 110,000 to USD 130,000. Healthcare providers, particularly in developing countries like India, Brazil, and Mexico, have low financial resources to invest in such costly technologies. he high cost of these systems, coupled with the challenge of a dearth of skilled personnel to operate digital pathology systems, is expected to limit the adoption of these systems.

Opportunity: Introduction of affordable scanners for private pathology practices

The price point of digital pathology hardware, including scanners, is a major restraint to market growth. Therefore, the development of affordable scanners is expected to offer growth opportunities for players operating in the digital pathology industry. Most private medical practices are small businesses and cannot afford expensive digital pathology systems. The introduction of affordable scanners and the propensity of small players to move towards digitization of pathology workflow will encourage its adoption among pathologists with low or limited budgets.

Challenge: Shortage of trained pathologists

The demand for pathology services has increased significantly for clinical applications due to the increasing prevalence of cancer. However, there is a gap between the supply and demand of pathologists worldwide, especially in Africa and the Asia Pacific region countries. According to Zippia, in 2021, the US had over 7,695 pathologists, 59.3% of them were women, while 40.7% were men. On the other hand, laboratories are under pressure to process an increasing number of specimens with limited staff. This is expected to hamper the growth of the cancer diagnostics market.

Digital Pathology Market Ecosystem Map

Digital Pathology Market Ecosystem

By product, the scanners segment is projected to lead the market of the Digital Pathology Industry in 2023

By product, the global digital pathology market is segmented into scanners, software, and storage systems. The software segment is projected to lead the global market in 2023 due to the  increased adoption of digital pathology software solutions in various healthcare facilities such as hospitals and diagnostic laboratories to utilize these solutions for remote primary diagnosis.

By type, the human pathology segment is projected to lead the market of the Digital Pathology Industry during the forecast period

By type, the digital pathology market is segmented into human pathology and veterinary pathology. The human pathology segment is projected to lead the global market in 2023. The highest growth of this segment can be attributed to the increasing number of cancer research activities , and growing collaborations among academic research institutes, universities, and pathology laboratories.

By application, the drug discovery segment is projected to lead the market of the Digital Pathology Industry in 2023

By application, the digital pathology market is segmented into drug discovery, disease diagnosis, and training & education. The drug discovery segment is projected to lead the global market during the forecast period due the growth in increasing use of toxicology testing for illicit drugs, the rising number of preclinical & clinical studies, and the rising pharmaceutical & biotechnology R&D expenditure.

By end user, the pharmaceutical & biotechnology companies is projected to lead the market of the Digital Pathology Industry during the forecast period

By end user, the digital pathology market is broadly segmented into pharmaceutical & biotechnology companies, hospitals & reference laboratories, and academic & research institutes. Pharmaceutical & biotechnology companies segment is projected to lead the global market in 2023. The high growth rate of this segment can be attributed to the advancing drug discovery and development, oncology clinical trials, and growing use of digital pathology for drug toxicology testing.

North America Region of the Digital Pathology Industry to witness significant growth from 2023 to 2028

On the basis of region, the digital pathology market is divided into North America, Europe, Asia Pacific, Latin America, and Middle east & Africa. In 2023, North America projected to lead market share of the nuclear medicine market. This can be attributed to the rising prevalence of cancer, increasing healthcare expenditure, and the favorable reimbursement in the region are driving the growth of the market in North America.

Digital Pathology Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Some of the prominent players operating in the digital pathology market include Fujifilm Holdings Corporation (Japan), Proscia Inc. (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China), Mikroscan Technologies, Inc. (US), PathAI (US), Danaher Corporation (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics K.K. (Japan), F. Hoffmann-La Roche Ltd. (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN, Inc. (US), Huron Digital Pathology (Canada), Hologic, Inc. (US), Corista (US), Indica Labs Inc. (US), Objective Pathology Services Limited (Canada), Sectra AB (Sweden), OptraSCAN (US), Akoya Biosciences, Inc. (US), Glencoe Software, Inc. (US), Aiforia (Finland), Paige AI, Inc. (US), Motic Digital Pathology (US), and Kanteron Systems (Spain).

Scope of the Digital Pathology Industry

Report Metric 

Details 

Market Revenue in 2023

$0.9 billion

Projected Revenue by 2028

$1.8 billion

Revenue Rate

Poised to Grow at a CAGR of 13.6%

Market Driver

Increasing adoption of digital pathology to enhance lab efficiency

Market Opportunity

Introduction of affordable scanners for private pathology practices

This report categorizes the global digital pathology market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • Scanners
    • Brightfield Scanners
    • Other Scanners
  • Software
    • Integrated Software
    • Standalone Software
  • Information Management Software
  • Image Visualization & Analysis Software
  • Storage Systems

By Type

  • Human Pathology
  • Veterinary Pathology

By Application

  • Drug Discovery
  • Disease Diagnosis
  • Training & Education

By End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Reference Laboratories
  • Academic & Research Institutes

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Sweden
    • Denmark
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East & Africa

Recent Developments of Digital Pathology Industry

  • In 2022, Danaher Corporation partnered with Indica Labs to deliver compatible digital pathology workflow solutions by maintaining file compatibility between Leica Biosystems Aperio GT 450 family of scanners with Indica Labs Halo family of software solutions.
  • In 2022, Hamamatsu received US FDA 510(k) clearance for the NanoZoomer S360MD Slide scanner system for primary diagnostic use.
  • In 2022, F. Hoffmann-LA roche ltd. Launched the VENTANA DP 600 slide scanner for digital pathology, enhancing patient care with precision diagnostics.
  • In 2021, Koninklijke Philips launched the next-generation digital pathology solution, which features a comprehensive and scalable suite of software tools and capabilities in digital pathology.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 33)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS OF STUDY
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
                    FIGURE 1 DIGITAL PATHOLOGY INDUSTRY
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY 
    1.5 STUDY LIMITATIONS 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
           1.7.1 ECONOMIC RECESSION IMPACT ON DIGITAL PATHOLOGY MARKET SIZE
 
2 RESEARCH METHODOLOGY (Page No. - 38)
    2.1 RESEARCH APPROACH 
    2.2 RESEARCH DESIGN 
          FIGURE 2 RESEARCH DESIGN
           2.2.1 SECONDARY RESEARCH
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY RESEARCH
                    FIGURE 3 PRIMARY SOURCES
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Insights from primary experts
                    2.2.2.3 Breakdown of primaries
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION 
          FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 6 MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION OF DANAHER CORPORATION
          FIGURE 7 BOTTOM-UP APPROACH
          FIGURE 8 CAGR PROJECTIONS
          FIGURE 9 IMPACT ON MARKET GROWTH AND CAGR: ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
    2.4 DATA TRIANGULATION APPROACH 
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.5 MARKET SHARE ANALYSIS 
    2.6 STUDY ASSUMPTIONS 
    2.7 RISK ASSESSMENT 
          TABLE 1 RISK ASSESSMENT: INDUSTRY
    2.8 MARKET LIMITATIONS 
           2.8.1 METHODOLOGY-RELATED LIMITATIONS
           2.8.2 SCOPE-RELATED LIMITATIONS
 
3 EXECUTIVE SUMMARY (Page No. - 53)
    FIGURE 11 DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 DIGITAL PATHOLOGY INDUSTRY, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 DIGITAL PATHOLOGY MARKET GROWTH, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MARKET
 
4 PREMIUM INSIGHTS (Page No. - 57)
    4.1 MARKET OVERVIEW 
          FIGURE 16 RISING PREVALENCE OF CANCER TO DRIVE MARKET
    4.2 NORTH AMERICA: DIGITAL PATHOLOGY INDUSTRY, BY END USER & COUNTRY (2022) 
          FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
    4.3 DIGITAL PATHOLOGY MARKET GROWTH: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 18 UK TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
    4.4 REGIONAL MIX: MARKET (2023–2028) 
          FIGURE 19 NORTH AMERICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD (2023–2028)
    4.5 MARKET: DEVELOPING VS. DEVELOPED MARKETS 
          FIGURE 20 DEVELOPED MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 61)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           FIGURE 21 DIGITAL PATHOLOGY MARKET SIZE: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing adoption of digital pathology to enhance lab efficiency
                    5.2.1.2 Rising incidence of cancer
                                 FIGURE 22 GLOBAL CANCER INCIDENCE, 2008–2030
                                 TABLE 2 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
                    5.2.1.3 Growing applications of digital pathology in drug development and companion diagnostics
                    5.2.1.4 Growing awareness of early cancer diagnosis in emerging economies
                    5.2.1.5 Recommendations for cancer screening
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of digital pathology systems
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Introduction of affordable scanners for private pathology practices
                    5.2.3.2 Growing demand for personalized medicine
                                 TABLE 3 US: GROWTH IN NUMBER OF PERSONALIZED MEDICINES, 2008–2020
                                 FIGURE 23 FDA-APPROVED PERSONALIZED MEDICINES, 2015–2021
                    5.2.3.3 High growth opportunities in emerging economies
           5.2.4 CHALLENGES
                    5.2.4.1 Shortage of trained pathologists
                                 TABLE 4 NUMBER OF INHABITANTS PER PATHOLOGIST, BY COUNTRY, 2020
    5.3 ECOSYSTEM MARKET MAP 
           FIGURE 24 DIGITAL PATHOLOGY INDUSTRY: ECOSYSTEM MARKET MAP
    5.4 PRICING ANALYSIS 
           FIGURE 25 AVERAGE SELLING PRICE TREND OF SCANNERS, BY REGION, 2018–2025
    5.5 IMPACT OF NEW IVD REGULATION ON DIFFERENT MARKETS 
           FIGURE 26 TIMELINE AND TRANSITION TO NEW MDR AND IVDR
           5.5.1 IMPACT ON CLINICAL LAB SERVICES
           5.5.2 IMPACT ON IVD
           5.5.3 IMPACT ON DIGITAL PATHOLOGY
    5.6 TECHNOLOGY ANALYSIS 
    5.7 ARTIFICIAL INTELLIGENCE (AI) IN DIGITAL PATHOLOGY 
           5.7.1 LABEL-FREE IMAGING IN DIGITAL PATHOLOGY
           5.7.2 COMPUTATIONAL IMAGE ANALYSIS IN DIGITAL PATHOLOGY
    5.8 PORTER’S FIVE FORCES ANALYSIS 
           5.8.1 THREAT OF NEW ENTRANTS
           5.8.2 THREAT OF SUBSTITUTES
           5.8.3 BARGAINING POWER OF SUPPLIERS
           5.8.4 BARGAINING POWER OF BUYERS
           5.8.5 INTENSITY OF COMPETITIVE RIVALRY
    5.9 KEY CONFERENCES & EVENTS, 2023–2024 
          TABLE 5 DIGITAL PATHOLOGY MARKET SIZE: DETAILED LIST OF CONFERENCES & EVENTS
    5.10 TARIFF AND REGULATORY ANALYSIS 
           5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.10.2 REGULATORY ANALYSIS
                    5.10.2.1 North America
                               5.10.2.1.1 US
                                               TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION
                                               TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                               5.10.2.1.2 Canada
                                               TABLE 9 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.10.2.2 Europe
                                 TABLE 10 EUROPE: CLASSIFICATION OF IVD DEVICES
                                 FIGURE 27 EUROPE: IVDR TIMELINE
                    5.10.2.3 Asia Pacific
                               5.10.2.3.1 Japan
                                               TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
                               5.10.2.3.2 China
                                               TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                               5.10.2.3.3 India
    5.11 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF DIGITAL PATHOLOGY PRODUCTS
                     TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF DIGITAL PATHOLOGY PRODUCTS (%)
           5.11.2 BUYING CRITERIA
                     FIGURE 29 KEY BUYING CRITERIA FOR DIGITAL PATHOLOGY PRODUCTS
                     TABLE 14 KEY BUYING CRITERIA FOR DIGITAL PATHOLOGY PRODUCTS
    5.12 PATENT ANALYSIS 
           5.12.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
                     FIGURE 30 TOP PATENT OWNERS AND APPLICANTS: MARKET (JANUARY 2011–FEBRUARY 2023)
                     FIGURE 31 TOP APPLICANT JURISDICTIONS FOR MARKET (JANUARY 2011–FEBRUARY 2023)
           5.12.2 PATENT PUBLICATION TRENDS FOR MARKET
                     FIGURE 32 PATENT ANALYSIS: MARKET (JANUARY 2011–FEBRUARY 2023)
                     TABLE 15 LIST OF PATENTS/PATENT APPLICATIONS IN MARKET, 2020–2023
 
6 DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT (Page No. - 89)
    6.1 INTRODUCTION 
          TABLE 16 DIGITAL PATHOLOGY INDUSTRY, BY PRODUCT, 2021–2028 (USD MILLION)
    6.2 SCANNERS 
          TABLE 17 SCANNING MAGNIFICATION AND APPLICATIONS
          TABLE 18 DIGITAL PATHOLOGY SCANNERS OFFERED BY KEY MARKET PLAYERS
          TABLE 19 DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 20 DIGITAL PATHOLOGY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.1 BRIGHTFIELD SCANNERS
                    6.2.1.1 Ideal solutions for small laboratories
                                TABLE 21 BRIGHTFIELD SCANNERS OFFERED BY KEY MARKET PLAYERS
                                TABLE 22 BRIGHTFIELD SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.2 OTHER SCANNERS
                    TABLE 23 OTHER SCANNERS OFFERED BY KEY MARKET PLAYERS
                    TABLE 24 OTHER SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 SOFTWARE 
          TABLE 25 DIGITAL PATHOLOGY SOFTWARE OFFERED BY KEY MARKET PLAYERS
          TABLE 26 DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 27 DIGITAL PATHOLOGY SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.1 INTEGRATED SOFTWARE
                    6.3.1.1 Includes various modules for different digital pathology applications
                                TABLE 28 INTEGRATED SOFTWARE OFFERED BY KEY MARKET PLAYERS
                                TABLE 29 INTEGRATED SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.2 STANDALONE SOFTWARE
                    TABLE 30 STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 31 STANDALONE SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.3.2.1 Information management software
                               6.3.2.1.1 Enables comprehensive integration with information systems of any institute
                                              TABLE 32 INFORMATION MANAGEMENT SOFTWARE OFFERED BY KEY MARKET PLAYERS
                                              TABLE 33 INFORMATION MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.3.2.2 Image analysis software
                               6.3.2.2.1 Provides easy-to-use solutions for quantitative evaluation of brightfield slides
                                              TABLE 34 IMAGE ANALYSIS SOFTWARE OFFERED BY KEY MARKET PLAYERS
                                              TABLE 35 IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.4 STORAGE SYSTEMS 
           6.4.1 NEED FOR SAFE AND RELIABLE STORAGE OF HIGH-QUALITY IMAGES TO DRIVE MARKET
                    TABLE 36 STORAGE SYSTEMS OFFERED BY KEY MARKET PLAYERS
                    TABLE 37 STORAGE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
7 DIGITAL PATHOLOGY MARKET SHARE, BY TYPE (Page No. - 106)
    7.1 INTRODUCTION 
          TABLE 38 DIGITAL PATHOLOGY MARKET GROWTH, BY TYPE, 2021–2028 (USD MILLION)
    7.2 HUMAN DIGITAL PATHOLOGY 
           7.2.1 INCREASING CANCER RESEARCH ACTIVITIES TO DRIVE MARKET
                    TABLE 39 MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 VETERINARY DIGITAL PATHOLOGY 
           7.3.1 REDUCTION IN TURNAROUND TIME FOR ANIMAL DISEASE DIAGNOSIS TO DRIVE MARKET
                    TABLE 40 MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
8 DIGITAL PATHOLOGY MARKET SHARE, BY APPLICATION (Page No. - 110)
    8.1 INTRODUCTION 
          TABLE 41 DIGITAL PATHOLOGY INDUSTRY, BY APPLICATION, 2021–2028 (USD MILLION)
          TABLE 42 PRODUCT CROSS-MAPPING FOR DIFFERENT APPLICATIONS
    8.2 DRUG DISCOVERY 
           8.2.1 LARGEST AND FASTEST-GROWING SEGMENT OF MARKET
                    TABLE 43 APPLICATIONS OF DIGITAL PATHOLOGY IN DRUG DISCOVERY
                    TABLE 44 MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 DISEASE DIAGNOSIS 
           8.3.1 USE OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN DIGITAL PATHOLOGY SOLUTIONS TO PROPEL MARKET
                    TABLE 45 MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 TRAINING & EDUCATION 
           8.4.1 DIGITAL PATHOLOGY CAN IMPROVE EDUCATION & TRAINING PROVIDED TO PATHOLOGISTS IN ACADEMIC INSTITUTES
                    TABLE 46 MARKET FOR TRAINING & EDUCATION, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 DIGITAL PATHOLOGY MARKET SHARE, BY END USER (Page No. - 116)
    9.1 INTRODUCTION 
          TABLE 47 DIGITAL PATHOLOGY MARKET GROWTH, BY END USER, 2021–2028 (USD MILLION)
          TABLE 48 PRODUCT CROSS-MAPPING FOR DIFFERENT END USERS
    9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
           9.2.1 RISING USE OF DIGITAL PATHOLOGY IN DRUG DEVELOPMENT TO DRIVE MARKET
                    TABLE 49 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
    9.3 HOSPITALS & REFERENCE LABORATORIES 
           9.3.1 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
                    TABLE 50 HOSPITAL DEPLOYMENT OF DIGITAL PATHOLOGY SOLUTIONS
                    TABLE 51 MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
    9.4 ACADEMIC & RESEARCH INSTITUTES 
           9.4.1 INCREASING INVESTMENTS FOR RESEARCH IN DISEASE DIAGNOSIS TO SUPPORT MARKET GROWTH
                    TABLE 52 DIGITAL PATHOLOGY MARKET GROWTH FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
 
10 DIGITAL PATHOLOGY MARKET SHARE, BY REGION (Page No. - 123)
     10.1 INTRODUCTION 
             FIGURE 33 DIGITAL PATHOLOGY INDUSTRY: GEOGRAPHIC GROWTH OPPORTUNITIES
             TABLE 53 DIGITAL PATHOLOGY MARKET SHARE, BY REGION, 2021–2028 (USD MILLION)
     10.2 NORTH AMERICA 
             10.2.1 IMPACT OF RECESSION ON NORTH AMERICAN DIGITAL PATHOLOGY MARKET FORECAST
                       FIGURE 34 NORTH AMERICA: MARKET SNAPSHOT
                       TABLE 54 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                       TABLE 55 NORTH AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                       TABLE 56 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 57 NORTH AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 58 NORTH AMERICA: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 59 NORTH AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 60 NORTH AMERICA: DIGITAL PATHOLOGY MARKET REPORT, BY APPLICATION, 2021–2028 (USD MILLION)
                       TABLE 61 NORTH AMERICA: DIGITAL PATHOLOGY INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.2.2 US
                        10.2.2.1 Rapidly increasing geriatric population and growing prevalence of chronic diseases to drive market
                                      TABLE 62 US: CANCER INCIDENCE, BY TYPE, 2020 VS. 2040
                                      TABLE 63 US: KEY MACROINDICATORS
                                      TABLE 64 US: DIGITAL PATHOLOGY MARKET FORECAST, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 65 US: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 66 US: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 67 US: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 68 US: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 69 US: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 70 US: DIGITAL PATHOLOGY MARKET REPORT, BY END USER, 2021–2028 (USD MILLION)
             10.2.3 CANADA
                        10.2.3.1 Increasing government initiatives for cancer awareness to drive market growth
                                      TABLE 71 CANADA: CANCER INCIDENCE, BY TYPE, 2020 VS. 2040
                                      TABLE 72 CANADA: DIGITAL PATHOLOGY INITIATIVES AND FUNDING
                                      TABLE 73 CANADA: KEY MACROINDICATORS
                                      TABLE 74 CANADA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 75 CANADA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 76 CANADA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 77 CANADA: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 78 CANADA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 79 CANADA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 80 CANADA: DIGITAL PATHOLOGY MARKET REPORT, BY END USER, 2021–2028 (USD MILLION)
     10.3 EUROPE 
             10.3.1 IMPACT OF RECESSION ON EUROPEAN DIGITAL PATHOLOGY MARKET FORECAST
                       TABLE 81 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                       TABLE 82 EUROPE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                       TABLE 83 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 84 EUROPE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 85 EUROPE: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 86 EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 87 EUROPE: DIGITAL PATHOLOGY MARKET REPORT, BY APPLICATION, 2021–2028 (USD MILLION)
                       TABLE 88 EUROPE: DIGITAL PATHOLOGY INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Rising government funding and initiatives to drive market
                                      TABLE 89 UK: CANCER INCIDENCE, BY TYPE, 2020 VS. 2040
                                      TABLE 90 UK: KEY MACROINDICATORS
                                      TABLE 91 UK: DIGITAL PATHOLOGY MARKET FORECAST, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 92 UK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 93 UK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 94 UK: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 95 UK: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 96 UK: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 97 UK: DIGITAL PATHOLOGY MARKET REPORT, BY END USER, 2021–2028 (USD MILLION)
             10.3.3 GERMANY
                        10.3.3.1 High healthcare expenditure and supportive research initiatives to drive market
                                      TABLE 98 GERMANY: CANCER INCIDENCE, BY TYPE, 2020 VS. 2040
                                      TABLE 99 GERMANY: KEY MACROINDICATORS
                                      TABLE 100 GERMANY: DIGITAL PATHOLOGY MARKET DEMAND, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 101 GERMANY: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 102 GERMANY: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 103 GERMANY: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 104 GERMANY: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 105 GERMANY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 106 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.4 SWEDEN
                        10.3.4.1 Increasing prevalence of chronic diseases to support market growth
                                      TABLE 107 SWEDEN: CANCER INCIDENCE, BY TYPE, 2020 VS. 2040
                                      TABLE 108 SWEDEN: KEY MACROINDICATORS
                                      TABLE 109 SWEDEN: DIGITAL PATHOLOGY MARKET FORECAST, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 110 SWEDEN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 111 SWEDEN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 112 SWEDEN: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 113 SWEDEN: DIGITAL PATHOLOGY MARKET DEMAND, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 114 SWEDEN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 115 SWEDEN: DIGITAL PATHOLOGY INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.3.5 DENMARK
                        10.3.5.1 Increasing deployment of digital pathology solutions to support market growth
                                      TABLE 116 DENMARK: CANCER INCIDENCE, BY TYPE, 2020 VS. 2040
                                      TABLE 117 DENMARK: KEY MACROINDICATORS
                                      TABLE 118 DENMARK: DIGITAL PATHOLOGY MARKET TRENDS, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 119 DENMARK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 120 DENMARK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 121 DENMARK: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 122 DENMARK: DIGITAL PATHOLOGY MARKET DEMAND, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 123 DENMARK: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 124 DENMARK: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.6 FRANCE
                        10.3.6.1 Increasing government funding and favorable insurance system to drive adoption
                                      TABLE 125 FRANCE: CANCER INCIDENCE, BY TYPE, 2020 VS. 2040
                                      TABLE 126 FRANCE: KEY MACROINDICATORS
                                      TABLE 127 FRANCE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 128 FRANCE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 129 FRANCE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 130 FRANCE: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 131 FRANCE: DIGITAL PATHOLOGY MARKET DEMAND, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 132 FRANCE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 133 FRANCE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.7 REST OF EUROPE
                       TABLE 134 REST OF EUROPE: DIGITAL PATHOLOGY MARKET TRENDS, BY PRODUCT, 2021–2028 (USD MILLION)
                       TABLE 135 REST OF EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 136 REST OF EUROPE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 137 REST OF EUROPE: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 138 REST OF EUROPE: DIGITAL PATHOLOGY MARKET DEMAND, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 139 REST OF EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                       TABLE 140 REST OF EUROPE: DIGITAL PATHOLOGY INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
     10.4 ASIA PACIFIC 
             10.4.1 IMPACT OF RECESSION ON ASIA PACIFIC DIGITAL PATHOLOGY MARKET TRENDS
                       FIGURE 35 ASIA PACIFIC: MARKET SNAPSHOT
                       TABLE 141 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)
                       TABLE 142 ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                       TABLE 143 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 144 ASIA PACIFIC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 145 ASIA PACIFIC: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 146 ASIA PACIFIC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 147 ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                       TABLE 148 ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Rising geriatric population to drive demand for digital pathology products
                                      TABLE 149 CHINA: CANCER INCIDENCE, BY TYPE, 2020 VS. 2040
                                      TABLE 150 CHINA: KEY MACROINDICATORS
                                      TABLE 151 CHINA: DIGITAL PATHOLOGY MARKET ANALYSIS, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 152 CHINA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 153 CHINA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 154 CHINA: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 155 CHINA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 156 CHINA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 157 CHINA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.3 JAPAN
                        10.4.3.1 Advanced healthcare infrastructure to support market growth
                                      TABLE 158 JAPAN: CANCER INCIDENCE, BY TYPE, 2020 VS. 2040
                                      TABLE 159 JAPAN: KEY MACROINDICATORS
                                      TABLE 160 JAPAN: DIGITAL PATHOLOGY MARKET TRENDS, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 161 JAPAN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 162 JAPAN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 163 JAPAN: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 164 JAPAN: DIGITAL PATHOLOGY MARKET ANALYSIS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 165 JAPAN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 166 JAPAN: DIGITAL PATHOLOGY INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.4.4 INDIA
                        10.4.4.1 Increasing awareness regarding benefits of digital pathology solutions to drive market
                                      TABLE 167 INDIA: CANCER INCIDENCE, BY TYPE, 2020 VS. 2040
                                      TABLE 168 INDIA: KEY MACROINDICATORS
                                      TABLE 169 INDIA: DIGITAL PATHOLOGY MARKET TRENDS, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 170 INDIA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 171 INDIA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 172 INDIA: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 173 INDIA: DIGITAL PATHOLOGY MARKET ANALYSIS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 174 INDIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 175 INDIA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.5 REST OF ASIA PACIFIC
                       TABLE 176 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET ANALYSIS, BY PRODUCT, 2021–2028 (USD MILLION)
                       TABLE 177 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 178 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 179 REST OF ASIA PACIFIC: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 180 REST OF ASIA PACIFIC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 181 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                       TABLE 182 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
     10.5 LATIN AMERICA 
             10.5.1 IMPACT OF RECESSION ON LATIN AMERICAN DIGITAL PATHOLOGY MARKET OVERVIEW
                       TABLE 183 LATIN AMERICA: DIGITAL PATHOLOGY MARKET RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
                       TABLE 184 LATIN AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                       TABLE 185 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 186 LATIN AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 187 LATIN AMERICA: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 188 LATIN AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 189 LATIN AMERICA: DIGITAL PATHOLOGY MARKET PREDICTION, BY APPLICATION, 2021–2028 (USD MILLION)
                       TABLE 190 LATIN AMERICA: DIGITAL PATHOLOGY INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.5.2 BRAZIL
                        10.5.2.1 Rising initiatives to drive adoption of digital pathology solutions
                                      TABLE 191 BRAZIL: CANCER INCIDENCE, BY TYPE, 2020 VS. 2040
                                      TABLE 192 BRAZIL: DIGITAL PATHOLOGY MARKET OVERVIEW, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 193 BRAZIL: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 194 BRAZIL: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 195 BRAZIL: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 196 BRAZIL: DIGITAL PATHOLOGY MARKET RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 197 BRAZIL: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 198 BRAZIL: DIGITAL PATHOLOGY MARKET PREDICTION, BY END USER, 2021–2028 (USD MILLION)
             10.5.3 MEXICO
                        10.5.3.1 Rising burden of cancer to drive uptake of digital pathology solutions
                                      TABLE 199 MEXICO: CANCER INCIDENCE, BY TYPE, 2020 VS. 2040
                                      TABLE 200 MEXICO: DIGITAL PATHOLOGY MARKET OVERVIEW, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 201 MEXICO: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 202 MEXICO: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 203 MEXICO: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 204 MEXICO: DIGITAL PATHOLOGY MARKET RESEARCH, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 205 MEXICO: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 206 MEXICO: DIGITAL PATHOLOGY MARKET PREDICTION, BY END USER, 2021–2028 (USD MILLION)
             10.5.4 REST OF LATIN AMERICA
                       TABLE 207 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET RESEARCH, BY PRODUCT, 2021–2028 (USD MILLION)
                       TABLE 208 REST OF LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 209 REST OF LATIN AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 210 REST OF LATIN AMERICA: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 211 REST OF LATIN AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 212 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET PREDICTION, BY APPLICATION, 2021–2028 (USD MILLION)
                       TABLE 213 REST OF LATIN AMERICA: DIGITAL PATHOLOGY INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA 
             10.6.1 INFRASTRUCTURAL DEVELOPMENTS TO SUPPORT MARKET GROWTH
             10.6.2 IMPACT OF RECESSION ON MIDDLE EAST & AFRICAN DIGITAL PATHOLOGY MARKET OVERVIEW
                       TABLE 214 MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY MARKET RESEARCH, BY PRODUCT, 2021–2028 (USD MILLION)
                       TABLE 215 MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 216 MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 217 MIDDLE EAST AND AFRICA: STANDALONE SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 218 MIDDLE EAST AND AFRICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                       TABLE 219 MIDDLE EAST AND AFRICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                       TABLE 220 MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY MARKET PREDICTION, BY END USER, 2021–2028 (USD MILLION)
 
11 COMPETITIVE LANDSCAPE (Page No. - 199)
     11.1 OVERVIEW 
     11.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 36 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DIGITAL PATHOLOGY MARKET
     11.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS 
             FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN DIGITAL PATHOLOGY INDUSTRY
     11.4 COMPETITIVE BENCHMARKING 
             TABLE 221 FOOTPRINT ANALYSIS OF COMPANIES IN MARKET
             TABLE 222 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES
             TABLE 223 APPLICATION FOOTPRINT ANALYSIS OF COMPANIES
             TABLE 224 END-USER FOOTPRINT ANALYSIS OF COMPANIES
             TABLE 225 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES
     11.5 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                       FIGURE 38 MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS (2022)
     11.6 COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS 
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 DYNAMIC COMPANIES
             11.6.3 STARTING BLOCKS
             11.6.4 RESPONSIVE COMPANIES
                       FIGURE 39 MARKET: COMPANY EVALUATION QUADRANT FOR SMES/ STARTUPS (2022)
     11.7 MARKET SHARE ANALYSIS 
             FIGURE 40 DIGITAL PATHOLOGY MARKET OVERVIEW: SHARE ANALYSIS, BY KEY PLAYER, 2022
             TABLE 226 DIGITAL PATHOLOGY INDUSTRY: DEGREE OF COMPETITION
     11.8 COMPETITIVE SCENARIO 
             11.8.1 PRODUCT LAUNCHES AND APPROVALS
                       TABLE 227 KEY PRODUCT LAUNCHES AND APPROVALS
             11.8.2 DEALS
                       TABLE 228 KEY DEALS
 
12 COMPANY PROFILES (Page No. - 216)
     12.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             12.1.1 DANAHER CORPORATION
                       TABLE 229 DANAHER CORPORATION: BUSINESS OVERVIEW
                       FIGURE 41 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
             12.1.2 KONINKLIJKE PHILIPS N.V.
                       TABLE 230 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
                       FIGURE 42 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
             12.1.3 HAMAMATSU PHOTONICS K.K.
                       TABLE 231 HAMAMATSU PHOTONICS K.K.: BUSINESS OVERVIEW
                       FIGURE 43 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2022)
             12.1.4 F. HOFFMANN-LA ROCHE LTD.
                       TABLE 232 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
                       FIGURE 44 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
             12.1.5 SECTRA AB
                       TABLE 233 SECTRA AB: BUSINESS OVERVIEW
                       FIGURE 45 SECTRA AB: COMPANY SNAPSHOT (2021)
             12.1.6 AKOYA BIOSCIENCES, INC.
                       TABLE 234 AKOYA BIOSCIENCES, INC.: BUSINESS OVERVIEW
                       FIGURE 46 AKOYA BIOSCIENCES, INC.: COMPANY SNAPSHOT (2022)
             12.1.7 3DHISTECH LTD.
                       TABLE 235 3DHISTECH LTD.: BUSINESS OVERVIEW
             12.1.8 APOLLO ENTERPRISE IMAGING CORP.
                       TABLE 236 APOLLO ENTERPRISE IMAGING CORP.: BUSINESS OVERVIEW
             12.1.9 XIFIN, INC.
                       TABLE 237 XIFIN, INC.: BUSINESS OVERVIEW
             12.1.10 HURON DIGITAL PATHOLOGY
                       TABLE 238 HURON DIGITAL PATHOLOGY: BUSINESS OVERVIEW
             12.1.11 HOLOGIC, INC.
                       TABLE 239 HOLOGIC, INC.: BUSINESS OVERVIEW
                       FIGURE 47 HOLOGIC, INC.: COMPANY SNAPSHOT (2022)
             12.1.12 CORISTA
                       TABLE 240 CORISTA: BUSINESS OVERVIEW
             12.1.13 INDICA LABS INC.
                       TABLE 241 INDICA LABS INC.: BUSINESS OVERVIEW
             12.1.14 OBJECTIVE PATHOLOGY SERVICES LIMITED
                       TABLE 242 OBJECTIVE PATHOLOGY SERVICES LIMITED: BUSINESS OVERVIEW
             12.1.15 OPTRASCAN INC.
                       TABLE 243 OPTRASCAN INC.: BUSINESS OVERVIEW
             12.1.16 GLENCOE SOFTWARE, INC.
                       TABLE 244 GLENCOE SOFTWARE, INC.: BUSINESS OVERVIEW
             12.1.17 AIFORIA TECHNOLOGIES OYJ
                       TABLE 245 AIFORIA TECHNOLOGIES OYJ: BUSINESS OVERVIEW
             12.1.18 PAIGE AI, INC.
                       TABLE 246 PAIGE AI, INC.: BUSINESS OVERVIEW
             12.1.19 FUJIFILM HOLDINGS CORPORATION
                       TABLE 247 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
                       FIGURE 48 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2021)
             12.1.20 PROSCIA INC.
                       TABLE 248 PROSCIA, INC.: BUSINESS OVERVIEW
     12.2 OTHER PLAYERS 
             12.2.1 PATHAI, INC.
             12.2.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD.
             12.2.3 MIKROSCAN TECHNOLOGIES, INC.
             12.2.4 MOTIC DIGITAL PATHOLOGY
             12.2.5 KANTERON SYSTEMS
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
13 APPENDIX (Page No. - 267)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

This study involved four major activities in estimating the size of the digital pathology market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), US Food and Drug Administration (FDA), National Health Service (NHS), Indian Council of Medical Research (ICMR), Association of Australian Medical Research Institutes (AAMRI), Asian Funds for Cancer Research (AFCR), Academic Medical Center (AMC), American Society for Clinical Pathology (ASCP), Digital Imaging and Communications in Medicine (DICOM), Digital Pathology Association (DPA), Annual Reports, SEC Filings, Investor Presentations, Journals, Publications from Government Sources and Professional Associations, Expert Interviews, and MarketsandMarkets Analysis.

Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the clinical decision support system market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the clinical decision support system market. The primary sources from the demand side included industry experts, consultants, healthcare providers, hospital administration, and government bodies. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

Breakdown of Primary Interviews

Digital Pathology Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Note 1: Companies are classified into tiers based on their total revenue. As of 2021: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

Note 2: C-level executives include CEOs, COOs, CTOs, and VPs. 

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

To know about the assumptions considered for the study, download the pdf brochure

OptraScan

Product Specialist

Huron Digital Pathology

General Manager

Koninklijke Philips N.V.

Chief Marketing Officer

Market Size Estimation

Bottom-up approaches was used to estimate and validate the total size of the digital pathology market. This method was also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides, in the provider, payer, and other industries.

Market Definition

Digital pathology is an image-based information environment for managing and interpreting pathology information generated from digitized glass slides. The process involves the conversion of glass slides to digital pathology slides using digital pathology scanning solutions. A digital image is then generated, which enables high-resolution viewing of the slide.

Key Stakeholders

  • Senior Management
  • Finance/Procurement Department
  • R&D Department

Report Objectives

  • To define, describe, and forecast the digital pathology market based on the product, type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall digital pathology market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely,
  • North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
  • To profile the key players and analyze their market shares and core competencies2
  • To track and analyze competitive developments such as product launches, partnerships, agreements, and collaborations in the overall digital pathology market
  • To benchmark players within the market using the proprietary "Company Evaluation Quadrant " framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

  • Product matrix, which gives a detailed comparison of the product portfolios of the top companies
  • Further breakdown of the Rest of the Asia Pacific digital pathology market into South Korea, Australia, New Zealand, and other countries
  • Further breakdown of the Rest of Europe digital pathology market into Italy, Spain, Belgium, Russia, the Netherlands, Switzerland, and other countries
  • Detailed analysis and profiling of additional market players (up to 5)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
HIT 2608
Published ON
Jun, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Digital Pathology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback